期刊文献+

心力衰竭患者肺部感染后炎性因子的变化研究 被引量:11

Changes of inflammatory factors of patients with pulmonary infection and heart failure
原文传递
导出
摘要 目的研究心力衰竭患者肺部感染后炎性因子的变化,为心力衰竭肺部感染的早期诊断和治疗提供参考依据。方法选取2014年6月-2015年10月医院的52例心力衰竭肺部感染患者为A组,52例心力衰竭患者为B组,52例肺部感染患者为C组,比较3组患者血清炎性因子水平,数据采用SAS 6.0软件进行统计分析。结果 A组的炎性因子白细胞介素-6(IL-6)、转化生长因子-β(TGF-β)、肿瘤坏死因子-α(TNF-α)、降钙素原(PCT)及前列腺素E2(PGE2)血清水平分别为(15.35±1.64)pg/ml、(28.98±2.59)ng/ml、(2.76±0.32)ng/ml、(19.39±2.84)ug/L及(252.52±27.97)pg/ml,其均高于B组及C组,差异有统计学意义(P<0.05)。结论心力衰竭患者肺部感染的炎性因子呈现高表达状态,且心功能分级及肺部感染程度均对患者上述指标影响较大。 OBJECTIVE To investigate the changes of inflammatory factors of patients with pulmonary infection and heart failure,so as to provide evidence for the early diagnosis and treatment of pulmonary infection in heart failure.METHODS A total of 52 patients with pulmonary infection and heart failure in our hospital from Jun.2014 to Oct.2015 were selected as the group A,52 patients with heart failure were selected as group B,and other 52 patients with pulmonary infection were selected as group C,then serum levels of inflammatory factors of three groups were compared.The data were analyzed by SAS 6.0.RESULTS The serum levels of inflammatory factors IL-6,TGF-β,TNF-α,PCT and PGE2 of group A were(15.35±1.64)pg/ml,(28.98±2.59)ng/ml,(2.76±0.32)ng/ml,(19.39±2.84)ug/L and(252.52±27.97)pg/ml,respectively,which were all higher than those of group B and of group C,(P〈0.05).CONCLUSIONThe inflammatory factors of patients with pulmonary infection and heart failure show high expression state,and the influence of heart function classification and pulmonary infection degree for those indexes are great.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第16期3666-3668,共3页 Chinese Journal of Nosocomiology
基金 河南省科技计划基金资助项目项目(16210231003)
关键词 心力衰竭 肺部感染 炎性因子 Heart failure Pulmonary infection Inflammatory factors
  • 相关文献

参考文献11

  • 1Jiskoot-Ermers ME,Antonius TA,Looijen-Salamon MG,et al.Irreversible respiratory failure in a full-term infant with features of pulmonary interstitial glycogenosis as well as bronchopulmonary dysplasia[J].AJP Rep,2015,5(2):e136-140.
  • 2Dean D,Kallel F,Ewald GA,et al.Reduction in driveline infection rates:results from the heartMateⅡmulticenter driveline Silicone Skin Interface(SSI)registry[J].J Heart Lung Transplant,2015,34(6):781-789.
  • 3Ducharme-Smith A,Katz BZ,Bobrowski AE,et al.Prevalence of BK polyomavirus infection and association with renal dysfunction in pediatric heart transplant recipients[J].J Heart Lung Transplant,2015,34(2):222-226.
  • 4de Miguel-Yanes JM,Gonzalo-Hernando C,Muoz-Rivas N,et al.First plasma glucose value after urgent admission and inhospital mortality in acutely decompensated heart failure[J].Heart Lung,2015,44(2):137-140.
  • 5Linder A,Arnold R,Boyd JH,et al.Heparin-binding protein measurement improves the prediction of severe infection with organ dysfunction in the emergency department[J].Crit Care Med,2015,43(11):2378-2386.
  • 6Duan HY,Liu DM,Qian P,et al.Effect of atorvastatin on plasma NT-proBNP and inflammatory cytokine expression in patients with heart failure[J].Genet Mol Res,2015,14(4):15739-15748.
  • 7熊彬,魏任雄,陈国方.慢性心力衰竭患者IL-6、sICAM-1的血浆表达及与BNP和心功能关系的相关性研究[J].中国卫生检验杂志,2013,23(14):2951-2952. 被引量:17
  • 8Panchenko LF,Moiseev VS,Pirozhkov SV,et al.Blood content of markers of inflammation and cytokines in patients with alcoholic cardiomyopathy and ischemic heart disease at various stages of heart failure[J].Kardiologiia,2015,55(3):41-48.
  • 9Lkhagva B,Lin YK,Kao YH,et al.Novel histone deacetylase inhibitor modulates cardiac peroxisome proliferator-activated receptors and inflammatory cytokines in heart failure[J].Pharmacology,2015,96(4):184-191.
  • 10Fosshaug LE,Dahl CP,Risnes I,et al.Altered levels of fatty acids and inflammatory and metabolic mediators in epicardial adipose tissue in patients with systolic heart failure[J].J Card Fail,2015,21(11):916-923.

二级参考文献9

  • 1Davis RC, Hobbs FDR, Lip GYH,et al. Clinical review: ABC of heart failure [ J ]. BMJ, 2000,320 (9) :39 - 42.
  • 2Mc Dermott MM, Feinglass J, Lee pi,et al. Systolic function, read- mission rates, and survival among consecutively hospitalized patients with congestive heart failure[J]. AM Heart J, 1997,134(4) :728 -736.
  • 3Braunwald E, Bristow MR. Congestive heart failure fifty years of pro- gress [ J ]. Circulation, 2000,102 (14) : 11 - 23.
  • 4Gopal DJ, Iqbal MN, Maisel A, et al. Updating the role of natriuret- ic peptide levels in cardiovascular disease. Posgrad MED, 2011, 123(7) :102 - 113.
  • 5Baykaktutan U. Effects of angiotensin II of nitroxide generation in growing and resting rat aortic endothelial cells[J]. Hypertents , 2003,21 ( 11 ) :2093 -2101.
  • 6Matsmofi S, Yamada T, Matoba Y, et al. Tumor necrosis factor in cardiomyopathy and myocarditis [J].Circulation,1992,21 (8) :431 - 439.
  • 7Tang WH, Girod JP, Lee M J, et al. Plasma B - type natriuretic pep- tide levels in ambulatory patients with established chronic symptom- atie heart failure[ J] . Circulation , 2003,16 (2) :2964 - 2966.
  • 8鄢盛恺.美国临床生化科学院检验医学实践指南:急性冠状动脉综合征和心力衰竭的生物标志物[J].临床检验杂志,2009,27(5). 被引量:14
  • 9急性心力衰竭诊断和治疗指南[J].中华心血管病杂志,2010,38(3):195-208. 被引量:835

共引文献16

同被引文献92

引证文献11

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部